Docking and small angle X-ray scattering studies of purine nucleoside phosphorylase.

Walter Filgueira de Azevedo,G. Dos Santos,D. M. D. dos Santos,J. R. Olivieri,F. Canduri,R. G. Silva,L. A. Basso,Gaby Renard,I. D. da Fonseca,M. Mendes,M. Palma,D. Santos

DOI: https://doi.org/10.1016/J.BBRC.2003.08.093

2003-10-03

Abstract:

What problem does this paper attempt to address?

The third generation sequencing: the advanced approach to genetic diseases

Tiantian Xiao,Wenhao Zhou

DOI: https://doi.org/10.21037/tp.2020.03.06

2020-04-01

Translational Pediatrics

Abstract:Genomic sequencing technologies have revolutionized mutation detection of the genetic diseases in the past few years. In recent years, the third generation sequencing (TGS) has been gaining insight into more genetic diseases owing to the single molecular and real time sequencing technology. This paper reviews the genomic sequencing revolutionary history first and then focuses on the genetic diseases discovered through the TGS and the clinical effects of the TGS, which is followed by the discussion of the improvement in the bioinformatic analysis for the TGS and its limitations. In summary, the TGS has been enhancing the diagnostic accuracy of genetic diseases in molecular level as well as paving a new way for basic researches and therapies.

pediatrics
[A consensus on the standardization of the next generation sequencing process for the diagnosis of genetic diseases (3) - Data analysis].

Jun Sun,Yi Huang,Xiaodong Wang,Wenfu Li,Dongyan An,Yong Gao,Hui Xiong,Zaiwei Zhou,Xiong Xu,Xuxu Deng,Xiaoqing Wang,Hui Huang,Zhiyu Peng,Wei Zhang,Shihui Yu,Liang Wang,Weihong Gu,Shangzhi Huang,Yiping Shen

DOI: https://doi.org/10.3760/cma.j.issn.1003-9406.2020.03.021

2020-01-01

Abstract:Bioinformatic analysis and variant classification are the key components of high-throughput sequencing-based genetic diagnostic approach. This consensus is part of the effort to develop a standardized process for next generation sequencing (NGS)-based test for germline mutations underlying Mendelian disorders in China. The flow-chart, common software, key parameters of bioinformatics pipeline for data processing, annotation, storage and variant classification are reviewed, which is aimed to help improving and maintaining a high-quality process and obtaining consistent outcomes for NGS-based molecular diagnosis.
Identification Of Sequence Variants In Genetic Disease-Causing Genes Using Targeted Next-Generation Sequencing

Xiaoming Wei,Xiangchun Ju,Xin Yi,Qian Zhu,Ning Qu,Tengfei Liu,Yang Chen,Hui Jiang,Guanghui Yang,Ruan Zhen,Zhangzhang Lan,Ming Qi,Jinming Wang,Yi Yang,Yuxing Chu,Xiaoyan Li,Yanfang Guang,Jian Huang

DOI: https://doi.org/10.1371/journal.pone.0029500

IF: 3.7

2011-01-01

PLoS ONE

Abstract:Background: Identification of gene variants plays an important role in research on and diagnosis of genetic diseases. A combination of enrichment of targeted genes and next-generation sequencing (targeted DNA-HiSeq) results in both high efficiency and low cost for targeted sequencing of genes of interest.Methodology/Principal Findings: To identify mutations associated with genetic diseases, we designed an array-based gene chip to capture all of the exons of 193 genes involved in 103 genetic diseases. To evaluate this technology, we selected 7 samples from seven patients with six different genetic diseases resulting from six disease-causing genes and 100 samples from normal human adults as controls. The data obtained showed that on average, 99.14% of 3,382 exons with more than 30-fold coverage were successfully detected using Targeted DNA-HiSeq technology, and we found six known variants in four disease-causing genes and two novel mutations in two other disease-causing genes (the STS gene for XLI and the FBN1 gene for MFS) as well as one exon deletion mutation in the DMD gene. These results were confirmed in their entirety using either the Sanger sequencing method or real-time PCR.Conclusions/Significance: Targeted DNA-HiSeq combines next-generation sequencing with the capture of sequences from a relevant subset of high-interest genes. This method was tested by capturing sequences from a DNA library through hybridization to oligonucleotide probes specific for genetic disorder-related genes and was found to show high selectivity, improve the detection of mutations, enabling the discovery of novel variants, and provide additional indel data. Thus, targeted DNA-HiSeq can be used to analyze the gene variant profiles of monogenic diseases with high sensitivity, fidelity, throughput and speed.
The Application of the High Throughput Sequencing Technology in the Transposable Elements

Zhen Liu,Jian-hong Xu

DOI: https://doi.org/10.16288/j.yczz.15-140

2015-01-01

Abstract:High throughput sequencing technology has dramatically improved the efficiency of DNA sequencing, and decreased the costs to a great extent. Meanwhile, this technology usually has advantages of better specificity, higher sensitivity and accuracy. Therefore, it has been applied to the research on genetic variations, transcriptomics and epigenomics. Recently, this technology has been widely employed in the studies of transposable elements and has achieved fruitful results. In this review, we summarize the application of high throughput sequencing technology in the fields of transposable elements, including the estimation of transposon content, preference of target sites and dis-tribution, insertion polymorphism and population frequency, identification of rare copies, transposon horizontal transfers as well as transposon tagging. We also briefly introduce the major common sequencing strategies and algo-rithms, their advantages and disadvantages, and the corresponding solutions. Finally, we envision the developing trends of high throughput sequencing technology, especially the third generation sequencing technology, and its ap-plication in transposon studies in the future, hopefully providing a comprehensive understanding and reference for related scientific researchers.
Design and analysis of group-randomized trials: a review of recent practices.

Sherri P. Varnell,D. Murray,Jessica B. Janega,Jonathan L. Blitstein

DOI: https://doi.org/10.2105/AJPH.94.3.393

2004-03-01

American Journal of Public Health

Abstract:We reviewed group-randomized trials (GRTs) published in the American Journal of Public Health and Preventive Medicine from 1998 through 2002 and estimated the proportion of GRTs that employ appropriate methods for design and analysis. Of 60 articles, 9 (15.0%) reported evidence of using appropriate methods for sample size estimation. Of 59 articles in the analytic review, 27 (45.8%) reported at least 1 inappropriate analysis and 12 (20.3%) reported only inappropriate analyses. Nineteen (32.2%) reported analyses at an individual or subgroup level, ignoring group, or included group as a fixed effect. Hence increased vigilance is needed to ensure that appropriate methods for GRTs are employed and that results based on inappropriate methods are not published.
Articulation at shoulder level--a pilot experimental study on car seat comfort.

D. Coelho,S. Dahlman

DOI: https://doi.org/10.1016/j.apergo.2011.03.003

IF: 3.94

Applied Ergonomics

Abstract:
Progress in the Application of CRISPR/Cas Family Mediated Third-generation Sequencing Technology

Xizhen Chen

DOI: https://doi.org/10.54097/a43yhk04

2024-09-14

Academic Journal of Science and Technology

Abstract:The first generation sequencing technology based on the dideoxynucleotide (ddNTP) chain termination method proposed by Sanger was gradually eliminated due to its high cost, low sequencing read length and cumbersome process. The second generation of sequencing technology, called High-throughput sequencing (HTS), which was then developed, still has the problem of fixed read length. In recent years, the third generation sequencing technology represented by SMRT technology and Nanopore sequencing technology has gradually become popular. Compared with the previous two generations of sequencing technology, the most significant advantage of the third generation sequencing technology is its ability to carry out single molecule sequencing. In this process, the infinite length of nucleic acid sequence can be determined theoretically without the help of PCR amplification. This paper first introduces the basic principles, advantages and disadvantages of third-generation sequencing, and introduces in detail the CRISPR/Cas family-mediated SMRT technology and Nanopore sequencing technology in the third-generation sequencing technology. Finally, the research progress and prospects of the combination of the third generation sequencing technology and gene editing technology in the future are analyzed.
Effect of protein binding on the penetration of nonmetabolized cephalosporins into atrial appendage and pericardial fluids in open-heart surgical patients

C. Nightingale,J. Klimek,R. Quintiliani

DOI: https://doi.org/10.1128/AAC.17.4.595

IF: 5.938

1980-04-01

Antimicrobial Agents and Chemotherapy

Abstract:At various times before surgery, 33 patients undergoing coronary artery bypass or cardiac valve replacement surgery received a single 2.0-g dose of either cefazolin or cephradine. Simultaneous single serum, atrial appendage, and pericardial fluid samples were obtained from the patients at various times and analyzed for drug content. Compared with cephradine, cefazolin yielded higher total serum, atrial appendage, and pericardial fluid levels. Unbound (free) levels of cephradine in serum and pericardial fluid were, however, higher than those of cefazolin. It remains uncertain whether the higher and more prolonged total levels of cefazolin in the right atrial appendage and in serum, or the higher free levels of cephradine in pericardial fluid and in serum, provide either one with a therapeutic advantage.
The bioinformatics tools for the genome assembly and analysis based on third-generation sequencing.

Jiachun Lu,Xiaoyan Li,S. Bhyan,Min Zhao,Yining Liu,YongKiat Wee

DOI: https://doi.org/10.1093/bfgp/ely037

2018-11-21

Briefings in Functional Genomics

Abstract:The application of third-generation sequencing (TGS) technology in genetics and genomics have provided opportunities to categorize and explore the individual genomic landscapes and mutations relevant for diagnosis and therapy using whole genome sequencing and de novo genome assembly. In general, the emerging TGS technology can produce high quality long reads for the determination of overlapping reads and transcript isoforms. However, this technology still faces challenges such as the accuracy for the identification of nucleotide bases and high error rates. Here, we surveyed 39 TGS-related tools for de novo assembly and genome analysis to identify the differences among their characteristics, such as the required input, the interaction with the user, sequencing platforms, type of reads, error models, the possibility of introducing coverage bias, the simulation of genomic variants and outputs provided. The decision trees are summarized to help researchers to find out the most suitable tools to analyze the TGS data. Our comprehensive survey and evaluation of computational features of existing methods for TGS may provide a valuable guideline for researchers.

Medicine,Computer Science,Biology
Advances in Nanopore and Photoelectron-Based High-Throughput Sequencing Technology for Single-Molecule Sequencing

Yunqi Huang,Yutong Lu,Cailing Song,Yican Wei,Yuxi Yang,Jie Ren,Meiling Wang,Congli Tang,Aayesha Riaz,Muhammad Ali Shah,Yan Deng,Hongna Liu,Wenjing Pan,Song Li

DOI: https://doi.org/10.1166/jno.2023.3419

2023-04-01

Journal of Nanoelectronics and Optoelectronics

Abstract:Next-Generation sequencing is a widespread technology of sequencing which is used in genomics research and biotechnology, although it comes with many shortcomings such as short read length or polymerase chain reactions (PCR) bias. In this review, a brief introduction is provided to the Helicos Biosciences true single-molecule sequencing (tSMS), Pacific Biosciences single-molecule real-time (SMRT) sequencing and Oxford Nanopore single-molecule sequencing technologies. In comparison with both first- and second-generation sequencing technologies, third-generation sequencing such as nanopore and photoelectron high-throughput sequencing technologies have the advantages of ultra-long read length and no PCR bias, which help to study repetitive regions of the genome and complex structural variants, thus correctly identifying potential gene mutations in various diseases, and are important for diagnosis and treatment of various diseases. This paper focuses on the sequencing principles of nanopore and photoelectron high-throughput sequencing technologies as well as their applications in cancer, pathogen detection and genetic diseases.

engineering, electrical & electronic,nanoscience & nanotechnology,physics, applied
Long read sequencing on its way to the routine diagnostics of genetic diseases

Giulia Olivucci,Emanuela Iovino,Giovanni Innella,Daniela Turchetti,Tommaso Pippucci,Pamela Magini

DOI: https://doi.org/10.3389/fgene.2024.1374860

IF: 3.7

2024-03-06

Frontiers in Genetics

Abstract:The clinical application of technological progress in the identification of DNA alterations has always led to improvements of diagnostic yields in genetic medicine. At chromosome side, from cytogenetic techniques evaluating number and gross structural defects to genomic microarrays detecting cryptic copy number variants, and at molecular level, from Sanger method studying the nucleotide sequence of single genes to the high-throughput next-generation sequencing (NGS) technologies, resolution and sensitivity progressively increased expanding considerably the range of detectable DNA anomalies and alongside of Mendelian disorders with known genetic causes. However, particular genomic regions (i.e., repetitive and GC-rich sequences) are inefficiently analyzed by standard genetic tests, still relying on laborious, time-consuming and low-sensitive approaches (i.e., southern-blot for repeat expansion or long-PCR for genes with highly homologous pseudogenes), accounting for at least part of the patients with undiagnosed genetic disorders. Third generation sequencing, generating long reads with improved mappability, is more suitable for the detection of structural alterations and defects in hardly accessible genomic regions. Although recently implemented and not yet clinically available, long read sequencing (LRS) technologies have already shown their potential in genetic medicine research that might greatly impact on diagnostic yield and reporting times, through their translation to clinical settings. The main investigated LRS application concerns the identification of structural variants and repeat expansions, probably because techniques for their detection have not evolved as rapidly as those dedicated to single nucleotide variants (SNV) identification: gold standard analyses are karyotyping and microarrays for balanced and unbalanced chromosome rearrangements, respectively, and southern blot and repeat-primed PCR for the amplification and sizing of expanded alleles, impaired by limited resolution and sensitivity that have not been significantly improved by the advent of NGS. Nevertheless, more recently, with the increased accuracy provided by the latest product releases, LRS has been tested also for SNV detection, especially in genes with highly homologous pseudogenes and for haplotype reconstruction to assess the parental origin of alleles with de novo pathogenic variants. We provide a review of relevant recent scientific papers exploring LRS potential in the diagnosis of genetic diseases and its potential future applications in routine genetic testing.

genetics & heredity
Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

Hong-Yan Liu,Liyuan Zhou,Meng-Yue Zheng,Jia Huang,Shu Wan,Aiying Zhu,Mingjie Zhang,Anliang Dong,Ling Hou,Jia Li,Haiming Xu,Bingjian Lu,Weiguo Lu,Pengyuan Liu,Yan Lu

DOI: https://doi.org/10.1038/s41598-019-55832-1

IF: 4.6

2019-01-01

Scientific Reports

Abstract:Rare diseases are usually chronically debilitating or even life-threatening with diagnostic and therapeutic challenges in current clinical practice. It has been estimated that 80% of rare diseases are genetic in origin, and thus genome sequencing-based diagnosis offers a promising alternative for rare-disease management. In this study, 79 individuals from 16 independent families were performed for whole-genome sequencing (WGS) in an effort to identify the causative mutations for 16 distinct rare diseases that are largely clinically intractable. Comprehensive analysis of variations, including simple nucleotide variants (SNVs), copy-number variations (CNVs), and structural variations (SVs), was implemented using the WGS data. A flexible analysis pipeline that allowed a certain degree of misclassification of disease status was developed to facilitate the identification of causative variants. As a result, disease-causing variants were identified in 10 of the 16 investigated diseases, yielding a diagnostic rate of 62.5%. Additionally, new potentially pathogenic variants were discovered for two disorders, including IGF2/INS-IGF2 in mitochondrial disease and FBN3 in Klippel–Trenaunay–Weber syndrome. Our WGS analysis not only detected a CNV associated with 3p deletion syndrome but also captured a simple sequence repeat (SSR) variation associated with Machado–Joseph disease. To our knowledge, this is the first time the clinical WGS analysis of short-read sequences has been used successfully to identify a causative SSR variation that perfectly segregates with a repeat expansion disorder. After the WGS analysis, we confirmed the initial diagnosis for three of 10 established disorders and modified or corrected the initial diagnosis for the remaining seven disorders. In summary, clinical WGS is a powerful tool for the diagnosis of rare diseases, and its diagnostic clarity at molecular levels offers important benefits for the participating families.
The Application of Long-Read Sequencing to Cancer

Luca Ermini,Patrick Driguez,Ermini,Driguez

DOI: https://doi.org/10.3390/cancers16071275

2024-03-26

Cancers

Abstract:Cancer is a multifaceted disease arising from numerous genomic aberrations that have been identified as a result of advancements in sequencing technologies. While next-generation sequencing (NGS), which uses short reads, has transformed cancer research and diagnostics, it is limited by read length. Third-generation sequencing (TGS), led by the Pacific Biosciences and Oxford Nanopore Technologies platforms, employs long-read sequences, which have marked a paradigm shift in cancer research. Cancer genomes often harbour complex events, and TGS, with its ability to span large genomic regions, has facilitated their characterisation, providing a better understanding of how complex rearrangements affect cancer initiation and progression. TGS has also characterised the entire transcriptome of various cancers, revealing cancer-associated isoforms that could serve as biomarkers or therapeutic targets. Furthermore, TGS has advanced cancer research by improving genome assemblies, detecting complex variants, and providing a more complete picture of transcriptomes and epigenomes. This review focuses on TGS and its growing role in cancer research. We investigate its advantages and limitations, providing a rigorous scientific analysis of its use in detecting previously hidden aberrations missed by NGS. This promising technology holds immense potential for both research and clinical applications, with far-reaching implications for cancer diagnosis and treatment.

oncology
Next-generation sequencing and its applications in molecular diagnostics

Zhenqiang Su,Baitang Ning,Hong Fang,Huixiao Hong,Roger Perkins,Weida Tong,Leming Shi

DOI: https://doi.org/10.1586/erm.11.3

2011-04-01

Expert Review of Molecular Diagnostics

Abstract:DNA sequencing is a powerful approach for decoding a number of human diseases, including cancers. The advent of next-generation sequencing (NGS) technologies has reduced sequencing cost by orders of magnitude and significantly increased the throughput, making whole-genome sequencing a possible way for obtaining global genomic information about patients on whom clinical actions may be taken. However, the benefits offered by NGS technologies come with a number of challenges that must be adequately addressed before they can be transformed from research tools to routine clinical practices. This article provides an overview of four commonly used NGS technologies from Roche Applied Science//454 Life Sciences, Illumina, Life Technologies and Helicos Biosciences. The challenges in the analysis of NGS data and their potential applications in clinical diagnosis are also discussed.

pathology
Application of third-generation sequencing to herbal genomics

Longlong Gao,Wenjie Xu,Tianyi Xin,Jingyuan Song

DOI: https://doi.org/10.3389/fpls.2023.1124536

2023-03-07

Abstract:There is a long history of traditional medicine use. However, little genetic information is available for the plants used in traditional medicine, which limits the exploitation of these natural resources. Third-generation sequencing (TGS) techniques have made it possible to gather invaluable genetic information and develop herbal genomics. In this review, we introduce two main TGS techniques, PacBio SMRT technology and Oxford Nanopore technology, and compare the two techniques against Illumina, the predominant next-generation sequencing technique. In addition, we summarize the nuclear and organelle genome assemblies of commonly used medicinal plants, choose several examples from genomics, transcriptomics, and molecular identification studies to dissect the specific processes and summarize the advantages and disadvantages of the two TGS techniques when applied to medicinal organisms. Finally, we describe how we expect that TGS techniques will be widely utilized to assemble telomere-to-telomere (T2T) genomes and in epigenomics research involving medicinal plants.
New-generation high-throughput technologies based 'omics' research strategy in human disease]

Xu Yang,Rui Jiao,Lin Yang,Li-Ping Wu,Ying-Rui Li,Jun Wang

DOI: https://doi.org/10.3724/SP.J.1005.2011.00829

2011-01-01

Abstract:In recent years, new-generation high-throughput technologies, including next-generation sequencing technology and mass spectrometry method, have been widely applied in solving biological problems, especially in human diseases field. This data driven, large-scale and industrialized research model enables the omnidirectional and multi-level study of human diseases from the perspectives of genomics, transcriptomics and proteomics levels, etc. In this paper, the latest development of the high-throughput technologies that applied in DNA, RNA, epigenomics, metagenomics including proteomics and some applications in translational medicine are reviewed. At genomics level, exome sequencing has been the hot spot of the recent research. However, the predominance of whole genome resequencing in detecting large structural variants within the whole genome level is coming to stand out as the drop of sequencing cost, which also makes it possible for personalized genome based medicine application. At trancriptomics level, e.g., small RNA sequencing can be used to detect known and predict unknown miRNA. Those small RNA could not only be the biomarkers for disease diagnosis and prognosis, but also show the potential of disease treatment. At proteomics level, e.g., target proteomics can be used to detect the possible disease-related protein or peptides, which can be useful index for clinical staging and typing. Furthermore, the application and development of trans-omics study in disease research are briefly introduced. By applying bioinformatics technologies for integrating multi-omics data, the mechanism, diagnosis and therapy of the disease are likely to be systemically explained and realized, so as to provide powerful tools for disease diagnosis and therapies.
Next-generation sequencing in the clinic: Promises and challenges

Jiekun Xuan,Ying Yu,Tao Qing,Lei Guo,Leming Shi

DOI: https://doi.org/10.1016/j.canlet.2012.11.025

IF: 9.756

2013-11-01

Cancer Letters

Abstract:The advent of next generation sequencing (NGS) technologies has revolutionized the field of genomics, enabling fast and cost-effective generation of genome-scale sequence data with exquisite resolution and accuracy. Over the past years, rapid technological advances led by academic institutions and companies have continued to broaden NGS applications from research to the clinic. A recent crop of discoveries have highlighted the medical impact of NGS technologies on Mendelian and complex diseases, particularly cancer. However, the ever-increasing pace of NGS adoption presents enormous challenges in terms of data processing, storage, management and interpretation as well as sequencing quality control, which hinder the translation from sequence data into clinical practice. In this review, we first summarize the technical characteristics and performance of current NGS platforms. We further highlight advances in the applications of NGS technologies towards the development of clinical diagnostics and therapeutics. Common issues in NGS workflows are also discussed to guide the selection of NGS platforms and pipelines for specific research purposes.

oncology
The Third-Generation Sequencing Challenge: Novel Insights for the Omic Sciences

Carmela Scarano,Iolanda Veneruso,Rosa Redenta De Simone,Gennaro Di Bonito,Angela Secondino,Valeria D'Argenio

DOI: https://doi.org/10.3390/biom14050568

IF: 6.064

2024-05-10

Biomolecules

Abstract:The understanding of the human genome has been greatly improved by the advent of next-generation sequencing technologies (NGS). Despite the undeniable advantages responsible for their widespread diffusion, these methods have some constraints, mainly related to short read length and the need for PCR amplification. As a consequence, long-read sequencers, called third-generation sequencing (TGS), have been developed, promising to overcome NGS. Starting from the first prototype, TGS has progressively ameliorated its chemistries by improving both read length and base-calling accuracy, as well as simultaneously reducing the costs/base. Based on these premises, TGS is showing its potential in many fields, including the analysis of difficult-to-sequence genomic regions, structural variations detection, RNA expression profiling, DNA methylation study, and metagenomic analyses. Protocol standardization and the development of easy-to-use pipelines for data analysis will enhance TGS use, also opening the way for their routine applications in diagnostic contexts.
Whole Genome Sequencing and Its Applications in Medical Genetics

Jiaxin Wu,Mengmeng Wu,Ting Chen,Rui Jiang

DOI: https://doi.org/10.1007/s40484-016-0067-0

2016-01-01

Quantitative Biology

Abstract:Fundamental improvement was made for genome sequencing since the next-generation sequencing (NGS) came out in the 2000s. The newer technologies make use of the power of massively-parallel short-read DNA sequencing, genome alignment and assembly methods to digitally and rapidly search the genomes on a revolutionary scale, which enable large-scale whole genome sequencing (WGS) accessible and practical for researchers. Nowadays, whole genome sequencing is more and more prevalent in detecting the genetics of diseases, studying causative relations with cancers, making genome-level comparative analysis, reconstruction of human population history, and giving clinical implications and instructions. In this review, we first give a typical pipeline of whole genome sequencing, including the lab template preparation, sequencing, genome assembling and quality control, variants calling and annotations. We compare the difference between whole genome and whole exome sequencing (WES), and explore a wide range of applications of whole genome sequencing for both mendelian diseases and complex diseases in medical genetics. We highlight the impact of whole genome sequencing in cancer studies, regulatory variant analysis, predictive medicine and precision medicine, as well as discuss the challenges of the whole genome sequencing.
Third-generation sequencing: A novel tool detects complex variants in the α-thalassemia gene

Ju Long,Lei Sun,Feifei Gong,Chenghong Zhang,Aiping Mao,Yulin Lu,Jiaqi Li,Enqi Liu

DOI: https://doi.org/10.1016/j.gene.2022.146332

IF: 3.913

2022-05-15

Gene

Abstract:Objective: Thalassemia is a monogenic disorder with a high carrier rate in the southern region of China. Most laboratories currently follow the protocol of testing hematologic indicators in individuals with positive hematologic indicators and then using the hot-spot mutation test kit. A novel thalassemia gene test is performed if there is a mismatch between the hematology and hot-spot mutation test results. However, due to the large population in southern China, some individuals carry complex α-globin gene cluster (CAGC) variants in NG_000006.1, which are difficult to detect using conventional thalassemia genetic analysis protocols, leading to missed or false genetic test results for individuals carrying these complex α-globin gene cluster variants. When an individual carries a complex α-thalassemia gene variant, and an individual carries a β- thalassemia gene variant, there may be clinical symptoms that might complicate clinical consultation and prenatal diagnosis if not accurately detected. Third-generation sequencing (TGS) enables long-read single-molecule sequencing with high detection accuracy, and long-length DNA chain reads in high-fidelity reads mode. TGS can be used to analyze high homology and rich GC DNA sequences. Results: Four samples that showed abnormalities in the thalassemia genetic test were studied using TGS, revealing that they carried genotypes with complex α-globin gene cluster variants, one of which was a complex variant αα anti3.7 α anti3.7 α 17.2. Conclusions: TGS detects complex α-globin gene cluster variants. This study may provide a reference protocol for the use of TGS for the detection of complex α-globin gene cluster variants. TGS can reveal individuals with complex α-thalassemia genotypes in the population and improve the accuracy of genetic counseling and prenatal diagnosis.

Docking and small angle X-ray scattering studies of purine nucleoside phosphorylase.

The third generation sequencing: the advanced approach to genetic diseases

[A consensus on the standardization of the next generation sequencing process for the diagnosis of genetic diseases (3) - Data analysis].

Identification Of Sequence Variants In Genetic Disease-Causing Genes Using Targeted Next-Generation Sequencing

The Application of the High Throughput Sequencing Technology in the Transposable Elements

Design and analysis of group-randomized trials: a review of recent practices.

Articulation at shoulder level--a pilot experimental study on car seat comfort.

Progress in the Application of CRISPR/Cas Family Mediated Third-generation Sequencing Technology

Effect of protein binding on the penetration of nonmetabolized cephalosporins into atrial appendage and pericardial fluids in open-heart surgical patients

The bioinformatics tools for the genome assembly and analysis based on third-generation sequencing.

Advances in Nanopore and Photoelectron-Based High-Throughput Sequencing Technology for Single-Molecule Sequencing

Long read sequencing on its way to the routine diagnostics of genetic diseases

Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

The Application of Long-Read Sequencing to Cancer

Next-generation sequencing and its applications in molecular diagnostics

Application of third-generation sequencing to herbal genomics

New-generation high-throughput technologies based 'omics' research strategy in human disease]

Next-generation sequencing in the clinic: Promises and challenges

The Third-Generation Sequencing Challenge: Novel Insights for the Omic Sciences

Whole Genome Sequencing and Its Applications in Medical Genetics

Third-generation sequencing: A novel tool detects complex variants in the α-thalassemia gene